Literature DB >> 8440438

Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis.

F Wong1, D Massie, P Hsu, F Dudley.   

Abstract

BACKGROUND: Patients with cirrhosis and ascites are especially sensitive to the adverse renal effects of indomethacin-induced inhibition of prostaglandin synthesis. The aim of this study was to determine whether indomethacin affects renal function in patients with well-compensated cirrhosis.
METHODS: Clearance techniques were used to assess renal hemodynamics and sodium and water homeostasis.
RESULTS: The oral administration of 50 mg of indomethacin to well-compensated patients with alcoholic cirrhosis was followed by a significant decrease in glomerular filtration rate (GFR) and effective renal plasma flow because of a preferential increase in afferent arteriolar tone. Indomethacin was both antidiuretic and antinatriuretic due principally to decreased free water clearance and increased proximal tubular reabsorption of sodium. The acute changes in renal function were not sustained. Patients with a high basal GFR were particularly sensitive to the adverse renal effects of indomethacin.
CONCLUSIONS: This study indicates that in patients with well-compensated cirrhosis renal prostaglandins are functionally active and may contribute to the pathogenesis of glomerular hyperfiltration. Nonsteroidal anti-inflammatory drugs should be used with caution in all patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440438     DOI: 10.1016/0016-5085(93)91024-c

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Anti-inflammatory drugs and variceal bleeding: a case-control study.

Authors:  V De Lédinghen; D Heresbach; O Fourdan; P Bernard; M P Liebaert-Bories; J B Nousbaum; A Gourlaouen; M C Becker; D Ribard; P Ingrand; C Silvain; M Beauchant
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 2.  Surgery in a patient with liver disease.

Authors:  Rakesh Rai; Sanjay Nagral; Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

3.  Medical Care of the Patient With Compensated Cirrhosis.

Authors:  Jorge L Herrera; Reynaldo Rodríguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-02

4.  Managing complications in cirrhotic patients.

Authors:  Markus Peck-Radosavljevic; Paolo Angeli; Juan Cordoba; Oliver Farges; Dominique Valla
Journal:  United European Gastroenterol J       Date:  2015-02       Impact factor: 4.623

5.  Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis.

Authors:  Sakib K Khalid; Jill Lane; Victor Navarro; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2009-04-24       Impact factor: 11.382

Review 6.  Evaluation and management of patients with refractory ascites.

Authors:  Bahaa Eldeen Senousy; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 7.  Hospice care for end stage liver disease in the United States.

Authors:  Eric S Orman; Amy W Johnson; Marwan Ghabril; Greg A Sachs
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-02-24       Impact factor: 4.095

Review 8.  The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations.

Authors:  Farnad Imani; Mahsa Motavaf; Saeid Safari; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-10-11       Impact factor: 0.660

9.  The assessment and management of pain in cirrhosis.

Authors:  Matthew Klinge; Tami Coppler; Jane M Liebschutz; Mohannad Dugum; Ajay Wassan; Andrea DiMartini; Shari Rogal
Journal:  Curr Hepatol Rep       Date:  2018-02-22

10.  Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study.

Authors:  Rianne A Weersink; Katja Taxis; Joost P H Drenth; Eline Houben; Herold J Metselaar; Sander D Borgsteede
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.